ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

RFAs Available

February 23, 1996

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

In Brief: Reagan Names David Korn New Chairman Of NCAB; Consensus Conference On Limb Sparing Planned

June 22, 1984

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000